Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations
Authors
Keywords
-
Journal
NEUROLOGICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-06
DOI
10.1007/s10072-023-07173-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers
- (2022) Gian Pal et al. ANNALS OF NEUROLOGY
- Neuroimaging in Glucocerebrosidase‐Associated Parkinsonism: A Systematic Review
- (2022) Massimo Filippi et al. MOVEMENT DISORDERS
- Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
- (2021) Taiji Tsunemi et al. MOVEMENT DISORDERS
- Should we start integrating genetic data in decision-making on device-aided therapies in Parkinson disease? A Point of View
- (2021) Philippe A. Salles et al. PARKINSONISM & RELATED DISORDERS
- DUOGLOBE : One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease
- (2021) David G. Standaert et al. Movement Disorders Clinical Practice
- EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
- (2019) Haidar S. Dafsari et al. MOVEMENT DISORDERS
- Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation
- (2019) Brian Lau et al. NEUROLOGY
- Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety
- (2019) Werner Poewe et al. Journal of Parkinsons Disease
- Parkinson disease
- (2019) R. Balestrino et al. EUROPEAN JOURNAL OF NEUROLOGY
- Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors
- (2019) Carlo Alberto Artusi et al. PARKINSONISM & RELATED DISORDERS
- Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications
- (2018) Roberta Balestrino et al. NEUROSCIENTIST
- BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders
- (2018) Ting Shen et al. Aging and Disease
- Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
- (2018) Regina Katzenschlager et al. LANCET NEUROLOGY
- Genetic background and outcome of Deep Brain Stimulation in Parkinson's disease
- (2018) Mario Giorgio Rizzone et al. PARKINSONISM & RELATED DISORDERS
- Rationale and patient selection for interventional therapies in Parkinson’s disease
- (2018) Junaid Siddiqui et al. Expert Review of Neurotherapeutics
- NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases
- (2017) Cornelis Blauwendraat et al. NEUROBIOLOGY OF AGING
- Survival and dementia inGBA-associated Parkinson's disease: The mutation matters
- (2016) Roberto Cilia et al. ANNALS OF NEUROLOGY
- Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment
- (2015) A. Merola et al. EUROPEAN JOURNAL OF NEUROLOGY
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
- (2014) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Calibration of unified Parkinson's disease rating scale scores toMovementDisorder Society-unified Parkinson's disease rating scale scores
- (2012) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- Levodopa–carbidopa intestinal gel for treatment of advanced Parkinson’s disease
- (2011) H.H. Fernandez et al. CURRENT MEDICAL RESEARCH AND OPINION
- Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease
- (2011) Maurizio Zibetti et al. MOVEMENT DISORDERS
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started